Study of the Combination of CM082 With Everolimus in Patients With mRCC

Clinical trial NCT02577458 · UNKNOWN

Trial details

NCT number: NCT02577458
Sponsor: AnewPharma
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Cell Carcinoma Recurrent

Start date: 2015-09-01
Primary completion: 2018-03-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.